McKinsey to pay $650m to settle US opioid consulting probe

Consulting firm McKinsey & Company has agreed to pay $650m to resolve a United States Department of Justice investigation into the consulting firm’s work advising opioid manufacturer Purdue Pharma on how to boost OxyContin sales.

McKinsey has entered into a five-year deferred prosecution agreement filed on Friday in federal court in Abingdon, Virginia, to resolve criminal charges brought as part of a rare corporate prosecution concerning the marketing of addictive painkillers that helped fuel the deadly US opioid epidemic.

Load More